RxDoctor Payments Data

Shawn Couture, MD

Family Medicine · Riverside, CANPI 1548464175

Payments from drug & device makers

$3,663in general payments, 2019–2025

Across 221 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$712
  • Novo Nordisk$608
  • Pfizer$315
  • Nestle Healthcare Nutrition Inc.$296
  • Novartis$272
  • GSK$226
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$3,663100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,663 in reported general payments places this provider in the 85th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$19,780
Medicare patients
106
Services billed
221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban157$141,458
JanuviaSitagliptin Phosphate30$32,465
XareltoRivaroxaban41$31,242
OzempicSemaglutide28$26,679
Acyclovir18$16,069
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$12,674
MounjaroTirzepatide11$11,156
Advair HfaFluticasone Propion/Salmeterol21$8,704
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen408$8,240
Spiriva RespimatTiotropium Bromide15$8,122
BrilintaTicagrelor14$7,040
Xtampza ErOxycodone Myristate12$5,802
DapagliflozinDapagliflozin Propanediol12$5,590
Atorvastatin Calcium501$5,311
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$5,099

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$315$141,458157 claims
MerckJanuvia$112$32,46530 claims
Johnson & JohnsonXarelto$94$31,24241 claims
Novo NordiskOzempic$608$26,67928 claims
Lilly USA, LLCMounjaro, Humalog$177$14,75427 claims
GSKTrelegy Ellipta$226$12,67412 claims
AstraZenecaBrilinta$15$7,04014 claims
Astellas Pharma US IncMyrbetriq$35$5,03212 claims
Sanofi-aventis U.S. LLCLantus$41$3,84822 claims
AbbVieSynthroid$712$1,47622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,533 family medicine providers in California.

Other family medicine in Riverside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →